PTC Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of March 2025: 0.21x

PTC Therapeutics Inc cash flow reinvestment rate. PTC Therapeutics Inc (PTCT) has a Cash Flow Reinvestment Rate of 0.21x as of March 2025, reinvesting $186.89 Million (capex $2.53 Million plus investments $-184.36 Million) from operating cash flow of $870.10 Million. See PTC Therapeutics Inc (PTCT) flexibility index to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.21x

(Capex + Investments) / Operating CF

Total Reinvested

$186.89 Million

Capex + Investments

Operating Cash Flow

$870.10 Million

USD

Capital Expenditures

$2.53 Million

USD

Cash Flow Reinvestment Rate of PTC Therapeutics Inc (2025–2025)

Cash flow reinvestment rate of PTC Therapeutics Inc from 2025 to 2025. Historical reinvestment intensity for PTC Therapeutics Inc across 1 annual periods. Explore PTCT operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

PTC Therapeutics Inc Cash Flow Reinvestment Rate by Year (2025–2025)

PTC Therapeutics Inc cash flow reinvestment rate by year from 2025 to 2025. Year-by-year capital reinvestment analysis for PTC Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of PTC Therapeutics Inc.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2025	0.80x	$570.90 Million	$711.20 Million	$8.86 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow